Literature DB >> 20533009

Mutation analysis of factor VIII in Korean patients with severe hemophilia A.

Chur-Woo You1, Hee-Sook Son, Hee Jin Kim, Eui-Jeon Woo, Soon-Ae Kim, Haing-Woon Baik.   

Abstract

Hemophilia A is an X-linked recessive disorder caused by mutations of the factor VIII gene. The mutation spectrum has been reported in various populations, but not in Koreans. Mutation analysis of the factor VIII gene was performed in 22 unrelated Korean patients with severe hemophilia A. We extracted genomic DNA from their blood, and assessed intron inversions, deletions, and point mutations by direct DNA sequencing. A multiplex ligation-dependent probe amplification gene dosage assay was also performed to identify exon deletions. Disease-causing mutations were identified in all patients, of which four cases were previously unreported. Seven intron 22 inversions, nine point mutations (6 nonsense mutations and 3 missense mutations), and four small rearrangements were identified. One multi-exon deletion and one 5'-donor splicing site mutation were also observed. Four novel mutations (one small deletion, one multiple exon deletion, one missense, and one splice site mutation) were detected, and point mutations were predominant (40.9%), followed by intron 22 inversions (31.8%). Further studies are required in order to establish a solid conclusion regarding the prevalence of various mutations in the Korean population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20533009     DOI: 10.1007/s12185-010-0593-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  40 in total

1.  Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.

Authors:  G C White; F Rosendaal; L M Aledort; J M Lusher; C Rothschild; J Ingerslev
Journal:  Thromb Haemost       Date:  2001-03       Impact factor: 5.249

2.  Site and type of mutations in the factor VIII gene in patients and carriers of haemophilia A.

Authors:  B D Theophilus; M S Enayat; M D Williams; F G Hill
Journal:  Haemophilia       Date:  2001-07       Impact factor: 4.287

3.  Single-tube polymerase chain reaction for rapid diagnosis of the inversion hotspot of mutation in hemophilia A.

Authors:  Q Liu; G Nozari; S S Sommer
Journal:  Blood       Date:  1998-08-15       Impact factor: 22.113

4.  Factor VIII gene inversions in severe hemophilia A: results of an international consortium study.

Authors:  S E Antonarakis; J P Rossiter; M Young; J Horst; P de Moerloose; S S Sommer; R P Ketterling; H H Kazazian; C Négrier; C Vinciguerra; J Gitschier; M Goossens; E Girodon; N Ghanem; F Plassa; J M Lavergne; M Vidaud; J M Costa; Y Laurian; S W Lin; S R Lin; M C Shen; D Lillicrap; S A Taylor; S Windsor; S V Valleix; K Nafa; Y Sultan; M Delpech; C L Vnencak-Jones; J A Phillips; R C Ljung; E Koumbarelis; A Gialeraki; T Mandalaki; P V Jenkins; P W Collins; K J Pasi; A Goodeve; I Peake; F E Preston; M Schwartz; E Scheibel; J Ingerslev; D N Cooper; D S Millar; V V Kakkar; F Giannelli; J A Naylor; E F Tizzano; M Baiget; M Domenech; C Altisent; J Tusell; M Beneyto; J I Lorenzo; C Gaucher; C Mazurier; K Peerlinck; G Matthijs; J J Cassiman; J Vermylen; P G Mori; M Acquila; D Caprino; H Inaba
Journal:  Blood       Date:  1995-09-15       Impact factor: 22.113

Review 5.  Incidence of inhibitors in haemophilia A patients--a review of recent studies of recombinant and plasma-derived factor VIII concentrates.

Authors:  I Scharrer; G L Bray; O Neutzling
Journal:  Haemophilia       Date:  1999-05       Impact factor: 4.287

6.  HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII.

Authors:  J Oldenburg; J K Picard; R Schwaab; H H Brackmann; E G Tuddenham; E Simpson
Journal:  Thromb Haemost       Date:  1997-02       Impact factor: 5.249

7.  Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A.

Authors:  Jan Astermark; Johannes Oldenburg; Anna Pavlova; Erik Berntorp; Ann-Kari Lefvert
Journal:  Blood       Date:  2005-12-27       Impact factor: 22.113

8.  The identification and classification of 41 novel mutations in the factor VIII gene (F8C).

Authors:  J A Cutler; M J Mitchell; M P Smith; G F Savidge
Journal:  Hum Mutat       Date:  2002-03       Impact factor: 4.878

Review 9.  Genetic risk factors for inhibitors to factors VIII and IX.

Authors:  J Oldenburg; A Pavlova
Journal:  Haemophilia       Date:  2006-12       Impact factor: 4.287

10.  Prevalence of small rearrangements in the factor VIII gene F8C among patients with severe hemophilia A.

Authors:  Nadja Bogdanova; Arseni Markoff; Hartmut Pollmann; Ulrike Nowak-Göttl; Roswith Eisert; Bernd Dworniczak; Antonin Eigel; Jürgen Horst
Journal:  Hum Mutat       Date:  2002-09       Impact factor: 4.878

View more
  3 in total

Review 1.  Violating the theory of single gene-single disorder: inhibitor development in hemophilia.

Authors:  Suad AlFadhli; Rasheeba Nizam
Journal:  Indian J Hematol Blood Transfus       Date:  2014-11-20       Impact factor: 0.900

2.  Heterogeneous lengths of copy number mutations in human coagulopathy revealed by genome-wide high-density SNP array.

Authors:  Hee-Jin Kim; Duk-Kyung Kim; Ki-Young Yoo; Chur-Woo You; Jong-Ha Yoo; Ki-O Lee; In-Ae Park; Hae-Sun Choung; Hee-Jung Kim; Min-Jung Song; Sun-Hee Kim
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

3.  The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A.

Authors:  Ju Young Kim; Chur Woo You
Journal:  Blood Res       Date:  2019-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.